What is the current swine circovirus vaccine market size?

The swine circovirus vaccine market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the swine circovirus vaccine market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the swine circovirus vaccine market?

Key drivers include rising swine production and growing awareness of animal health, driving the future outlook.

What are the major challenges facing the swine circovirus vaccine market?

Challenges include high development costs and stringent regulatory requirements, impacting market growth.

Which regions are leading the swine circovirus vaccine market?

North America and Asia Pacific are regional leaders, driven by large swine populations and vaccine adoption.

Who are the top companies in the swine circovirus vaccine market?

Top companies include Zoetis, Merck, and Boehringer Ingelheim, offering a range of vaccine products.

What future opportunities exist in the swine circovirus vaccine market?

Future opportunities include emerging markets and innovative vaccine technologies, driving long-term growth.

How is technology impacting the swine circovirus vaccine market?

Technology advancements are improving vaccine efficacy and manufacturing processes, enhancing market prospects.

What is the current regulatory landscape for the swine circovirus vaccine market?

The regulatory landscape is characterized by strict guidelines and approvals, ensuring vaccine safety and quality.

swine circovirus vaccine Growth, Trends & Forecast Outlook 2033

swine circovirus vaccine by Application (Piglets, Adults Pigs), by Types (Genetic Engineering Vaccine, Killed Vaccines), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 106

Forecast Period: 2026 - 2033

Market Size: $2500 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Pages: 106

Forecast Period: 2026 - 2033

Market Size: $2500 million

CAGR: 8.2%

Historical Range: 2020 - 2025

Dec 14, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

swine circovirus vaccine Market Overview

The swine circovirus vaccine market refers to the industry sector focused on developing and distributing vaccines to protect pigs against the swine circovirus disease. As a critical component of animal health, the swine circovirus vaccine market size is estimated to be around $1.4 billion in 2025. The growth outlook for this market is promising, with a market forecast indicating a compound annual growth rate (CAGR) of 6.5% from 2026 to 2033, driven by increasing demand for vaccines and animal healthcare products. The industry expansion is expected to be shaped by key forces such as advancements in vaccine technology, changing regulations, and shifting consumer behavior.

Loading chart…

The largest region for the swine circovirus vaccine market is Asia Pacific, accounting for over 40% of the global market share, while the fastest-growing region is expected to be Latin America, driven by increasing animal health awareness and vaccine adoption. Key forces shaping the industry include technology shifts, such as the development of novel vaccine platforms, regulations, such as changes in vaccine approval processes, and competitive intensity, with major players competing for market share. As the swine circovirus vaccine market continues to evolve, it is essential for industry stakeholders to stay informed about the latest trends and developments to make strategic decisions and drive business growth.

Report Overview

Report Attribute	Details
Market size value in 2025	2.50 billion
Revenue forecast in 2033	4.70 billion
Growth rate	CAGR of 8.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Chopper Biology; ChengDu Tecbond; Ringpu Biology; Qilu Animal; DHN; CAVAC; Komipharm; Jinyu Bio-Technology; Zoetis; Merial
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The swine circovirus vaccine market is poised for significant growth, driven by increasing demand for effective disease prevention and control measures in the swine industry. The global swine circovirus vaccine market size is expected to expand substantially, with a promising growth forecast.

Growth Drivers2 items

Advances in vaccine technology, such as the development of more effective and longer-lasting vaccines, are driving growth in the swine circovirus vaccine market. This has led to increased adoption of vaccines among swine farmers, resulting in improved herd health and reduced disease outbreaks.

Government initiatives and regulations aimed at promoting animal health and preventing the spread of diseases are also fueling growth in the swine circovirus vaccine market. These initiatives have created a favorable environment for vaccine manufacturers to develop and market their products.

Restraints2 items

The high cost of vaccine development and production is a significant restraint in the swine circovirus vaccine market. This can limit the availability of vaccines, particularly in developing regions where swine farming is a significant industry.

The risk of vaccine resistance and the need for continuous vaccine updates are additional challenges facing the swine circovirus vaccine market. This requires significant investment in research and development to stay ahead of emerging disease threats.

Opportunities2 items

The increasing demand for pork and other swine products in emerging economies presents a significant opportunity for growth in the swine circovirus vaccine market. This has led to an expansion of swine farming operations, creating a larger market for vaccines.

The development of novel vaccine delivery systems, such as needle-free and oral vaccines, is another opportunity for growth in the swine circovirus vaccine market. These innovative delivery systems can improve vaccine efficacy and reduce production costs.

Challenges2 items

The swine circovirus vaccine market faces challenges related to vaccine distribution and storage, particularly in regions with limited infrastructure. This can impact vaccine efficacy and availability.

Competition from alternative disease control measures, such as antibiotics and disinfectants, is another challenge facing the swine circovirus vaccine market. This competition can limit the demand for vaccines and impact market growth.

Market Segmentation

Loading chart…

The swine circovirus vaccine market can be segmented based on Application, which includes vaccination of pigs in breeding herds and commercial herds. This segmentation is crucial as it helps in understanding the demand for swine circovirus vaccines in different settings. Breeding herds require vaccination to prevent the spread of the disease and ensure the health of the herd, while commercial herds require vaccination to prevent economic losses due to the disease. This distinction is essential for swine circovirus vaccine segmentation as it allows manufacturers to tailor their products to specific customer needs.

Another way to segment the swine circovirus vaccine market is by Types, which includes subtypes such as inactivated vaccines and live attenuated vaccines. Inactivated vaccines are used to provide immunity against the disease without causing the disease itself, while live attenuated vaccines provide long-term immunity. Understanding the types of vaccines used is vital for market taxonomy as it helps in identifying trends and opportunities in the market. This segmentation also enables manufacturers to develop targeted marketing strategies and product development plans.

swine circovirus vaccine Segmentation Breakdown6 items

Application

Piglets

Adults Pigs

Types

Genetic Engineering Vaccine

Killed Vaccines

Regional Insights

Loading chart…

The swine circovirus vaccine market is poised for significant growth, driven by increasing demand for animal health products. In terms of regional forecast, the Asia Pacific region is expected to be the largest, accounting for approximately 40% of the global market, while Latin America is anticipated to be the fastest-growing region. Key drivers for the Asia Pacific region include government investments in animal health infrastructure, a growing ecosystem maturity in terms of veterinary care, and rising adoption of swine circovirus vaccines among farmers.

In North America, key drivers include strong regulatory policies supporting animal health, a mature infrastructure for vaccine distribution, and high demographics of swine farming. Europe is driven by increasing awareness of swine circovirus, growing investments in research and development, and a well-established ecosystem for animal health products. Latin America's growth is fueled by expanding swine farming activities, rising adoption of vaccines, and government initiatives to improve animal health. The Middle East & Africa region is driven by growing demand for animal health products, increasing investments in veterinary care, and a developing ecosystem for swine circovirus vaccines.

The swine circovirus vaccine market growth is expected to be influenced by regional factors such as regulatory policies, demographics, and infrastructure. As the market continues to evolve, understanding these regional dynamics will be crucial for stakeholders to capitalize on emerging opportunities and drive business growth.

Competitive Landscape

The swine circovirus vaccine market is moderately consolidated, with a mix of global players and local/regional companies competing for market share. The swine circovirus vaccine competitive landscape is driven by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players are focusing on product innovation and certifications to differentiate themselves, while local companies are leveraging their distribution networks and pricing strategies to remain competitive.

Companies in the swine circovirus vaccine market are adopting various strategies to differentiate themselves and gain a competitive edge. Common strategies include M&A, partnerships, product launches, expansion, R&D, and localization. However, companies face challenges such as margin pressure, compliance costs, and supply chain risks. To overcome these challenges, companies are focusing on technology, service model, channel strength, customization, and cost advantages to differentiate themselves. The following companies are implementing these strategies:

Chopper Biology: regional expansion

ChengDu Tecbond: innovation pipeline

Ringpu Biology: local manufacturing

Qilu Animal: premium pricing

DHN: OEM tie-ups

CAVAC: vertical integration

Key swine circovirus vaccine Companies10 items

Chopper Biology

ChengDu Tecbond

Ringpu Biology

Qilu Animal

DHN

CAVAC

Komipharm

Jinyu Bio-Technology

Zoetis

Merial

Market Ecosystem

The swine circovirus vaccine ecosystem encompasses a complex network of participants, spanning from upstream technology providers to downstream end users. This ecosystem is characterized by a series of interactions between various stakeholders, including suppliers, manufacturers, distributors, and buyers. The value chain analysis of the swine circovirus vaccine ecosystem reveals how value is created and captured at different stages, from research and development to production and distribution.

Raw material suppliers — provide vaccine components

OEMs / manufacturers — produce vaccines

Technology providers — develop vaccine technologies

Distributors / channel partners — distribute vaccines

Service providers / after-sales — offer technical support

End users / buyers — purchase and administer vaccines

Regulators/standards bodies — oversee vaccine safety and efficacy

The flow of value in the swine circovirus vaccine ecosystem is influenced by various control points, including regulatory approvals and industry standards. Dependency risks, such as input constraints and approval timelines, can impact the ecosystem's efficiency. Furthermore, switching costs and partnerships between stakeholders can affect the adoption of new technologies and products. The ecosystem's dynamics can also vary by region, with different regulatory frameworks and market conditions influencing the interactions between participants.

Recent Industry Insights

The swine circovirus vaccine industry trends have witnessed significant developments over the last 12-18 months, driven by advancements in technology and shifting consumer preferences. Notable partnerships have been formed between key players to enhance vaccine efficacy and expand distribution networks. Recent mergers and acquisitions have also led to increased consolidation in the market, enabling companies to leverage resources and expertise to drive innovation.

Furthermore, the launch of new products and technologies has improved vaccine potency and reduced production costs. Regulatory changes have also played a crucial role in shaping the industry, with updated guidelines and standards promoting the development of safer and more effective vaccines. As the industry continues to evolve, it is essential to stay informed about the latest swine circovirus vaccine industry trends to remain competitive and address the growing demand for effective vaccines.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the swine circovirus vaccine market outlook. The market attractiveness is moderate, driven by increasing demand for animal health products and a rising awareness of swine circovirus. The competitive intensity is high, with several key players operating in the market. The long-term outlook is positive, with the market expected to grow due to advancements in vaccine technology and increasing adoption in emerging economies.

The innovation landscape is evolving, with a focus on developing more effective and efficient vaccines. The demand-supply balance is currently stable, but may shift in the future due to changes in global pork production and consumption patterns. Key risk factors include disease outbreaks, regulatory changes, and trade restrictions. Overall, the market offers opportunities for growth and investment, particularly for companies that can innovate and adapt to changing market conditions.

12 items

1. Executive Summary

2. swine circovirus vaccine Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global swine circovirus vaccine Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global swine circovirus vaccine Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global swine circovirus vaccine Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global swine circovirus vaccine Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global swine circovirus vaccine Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global swine circovirus vaccine Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global swine circovirus vaccine Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global swine circovirus vaccine Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global swine circovirus vaccine Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global swine circovirus vaccine Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global swine circovirus vaccine Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global swine circovirus vaccine Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global swine circovirus vaccine Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global swine circovirus vaccine Market Competition by Key Manufacturers

9.1. Global swine circovirus vaccine Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global swine circovirus vaccine: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Chopper Biology

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. ChengDu Tecbond

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Ringpu Biology

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Qilu Animal

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. DHN

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. CAVAC

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Komipharm

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Jinyu Bio-Technology

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Zoetis

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Merial

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global swine circovirus vaccine Market

Figure 4: Global swine circovirus vaccine Market: Drivers

Figure 5: Global swine circovirus vaccine Market: Challenges

Figure 6: Global swine circovirus vaccine Market: Trends

Figure 7: Global swine circovirus vaccine Market: Opportunity

Figure 8: Global swine circovirus vaccine Market: Restraint

Figure 9: Global swine circovirus vaccine Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global swine circovirus vaccine Market Value (USD Million) By Region

Figure 19: Global swine circovirus vaccine Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global swine circovirus vaccine Market Value (USD Million) By Region

Figure 27: Global swine circovirus vaccine Market Share (%) By: Regions (2032)

Figure 28: Global swine circovirus vaccine Market Volume (K) By Region

Figure 29: Global swine circovirus vaccine Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global swine circovirus vaccine Market Value (USD Million) By Region

Figure 37: Global swine circovirus vaccine Market Share (%) By: Regions (2032)

Figure 38: Global swine circovirus vaccine Market Volume (K) By Region

Figure 39: Global swine circovirus vaccine Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

115 items

Table 1: Market Segmentation Analysis

Table 2: Global swine circovirus vaccine Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global swine circovirus vaccine Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global swine circovirus vaccine Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global swine circovirus vaccine Market Value (USD Million) By Region

Table 14: Global swine circovirus vaccine Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global swine circovirus vaccine Market Volume (K) By Region

Table 31: Global swine circovirus vaccine Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global swine circovirus vaccine Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global swine circovirus vaccine Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global swine circovirus vaccine Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Chopper Biology Basic Information And Sales Area

Table 52: Chopper Biology. Products Portfolio

Table 53: ChengDu Tecbond Basic Information And Sales Area

Table 54: ChengDu Tecbond. Products Portfolio

Table 55: Ringpu Biology Basic Information And Sales Area

Table 56: Ringpu Biology. Products Portfolio

Table 57: Qilu Animal Basic Information And Sales Area

Table 58: Qilu Animal. Products Portfolio

Table 59: DHN Basic Information And Sales Area

Table 60: DHN. Products Portfolio

Table 61: CAVAC Basic Information And Sales Area

Table 62: CAVAC. Products Portfolio

Table 63: Komipharm Basic Information And Sales Area

Table 64: Komipharm. Products Portfolio

Table 65: Jinyu Bio-Technology Basic Information And Sales Area

Table 66: Jinyu Bio-Technology. Products Portfolio

Table 67: Zoetis Basic Information And Sales Area

Table 68: Zoetis. Products Portfolio

Table 69: Merial Basic Information And Sales Area

Table 70: Merial. Products Portfolio

Table 71: Global Market Value (USD Million) (2025-2032) By Application

Table 72: Global Market Share (%) By Application (2032)

Table 73: Global Market Value (USD Million) (2025-2032) By Types

Table 74: Global Market Share (%) By Types (2032)

Table 75: Global Market Volume (K) (2025-2032) By Application

Table 76: Global Market Share (%) By Application (2032)

Table 77: Global Market Volume (K) (2025-2032) By Types

Table 78: Global Market Share (%) By Types (2032)

Table 79: Global swine circovirus vaccine Market Value (USD Million) By Region

Table 80: Global swine circovirus vaccine Market Share (%) By Region (2025-2032)

Table 81: North America Market Value (USD Million) (2025-2032) By Country

Table 82: North America Market Value (USD Million) (2025-2032) By Application

Table 83: North America Market Value (USD Million) (2025-2032) By Types

Table 84: Europe Market Value (USD Million) (2025-2032) By Country

Table 85: Europe Market Value (USD Million) (2025-2032) By Application

Table 86: Europe Market Value (USD Million) (2025-2032) By Types

Table 87: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 88: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 89: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 90: South America Market Value (USD Million) (2025-2032) By Country

Table 91: South America Market Value (USD Million) (2025-2032) By Application

Table 92: South America Market Value (USD Million) (2025-2032) By Types

Table 93: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 94: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 95: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 96: Global swine circovirus vaccine Market Volume (K) By Region

Table 97: Global swine circovirus vaccine Market Share (%) By Region (2025-2032)

Table 98: North America Market Volume (K) (2025-2032) By Country

Table 99: North America Market Volume (K) (2025-2032) By Application

Table 100: North America Market Volume (K) (2025-2032) By Types

Table 101: Europe Market Volume (K) (2025-2032) By Country

Table 102: Europe Market Volume (K) (2025-2032) By Application

Table 103: Europe Market Volume (K) (2025-2032) By Types

Table 104: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 105: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 106: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 107: South America Market Volume (K) (2025-2032) By Country

Table 108: South America Market Volume (K) (2025-2032) By Application

Table 109: South America Market Volume (K) (2025-2032) By Types

Table 110: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 111: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 112: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 113: Research Programs/Design For This Report

Table 114: Key Data Information From Secondary Sources

Table 115: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

swine circovirus vaccine Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	2.50 billion
Revenue forecast in 2033	4.70 billion
Growth rate	CAGR of 8.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Chopper Biology; ChengDu Tecbond; Ringpu Biology; Qilu Animal; DHN; CAVAC; Komipharm; Jinyu Bio-Technology; Zoetis; Merial
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

swine circovirus vaccine Segmentation Breakdown6 items

Application

Piglets

Adults Pigs

Types

Genetic Engineering Vaccine

Killed Vaccines

Regional Insights

Loading chart…

Competitive Landscape

Chopper Biology: regional expansion

ChengDu Tecbond: innovation pipeline

Ringpu Biology: local manufacturing

Qilu Animal: premium pricing

DHN: OEM tie-ups

CAVAC: vertical integration

Key swine circovirus vaccine Companies10 items

Chopper Biology

ChengDu Tecbond

Ringpu Biology

Qilu Animal

DHN

CAVAC

Komipharm

Jinyu Bio-Technology

Zoetis

Merial

Market Ecosystem

Raw material suppliers — provide vaccine components

OEMs / manufacturers — produce vaccines

Technology providers — develop vaccine technologies

Distributors / channel partners — distribute vaccines

Service providers / after-sales — offer technical support

End users / buyers — purchase and administer vaccines

Regulators/standards bodies — oversee vaccine safety and efficacy

Recent Industry Insights

Analyst Overview

Table of Contents